DIFFUSION PHARMACEUTICALS IN's ticker is and the CUSIP is 253748305. A total of 12 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $214,000 | -18.0% | 858,408 | 0.0% | 0.00% | – |
| Q4 2021 | $261,000 | -40.3% | 858,408 | 0.0% | 0.00% | – |
| Q3 2021 | $437,000 | -25.6% | 858,408 | +6.7% | 0.00% | – |
| Q2 2021 | $587,000 | -8.6% | 804,290 | +14.9% | 0.00% | – |
| Q1 2021 | $642,000 | +216.3% | 700,038 | +173.8% | 0.00% | – |
| Q4 2020 | $203,000 | -5.6% | 255,687 | 0.0% | 0.00% | – |
| Q3 2020 | $215,000 | -35.0% | 255,687 | -24.8% | 0.00% | – |
| Q2 2020 | $331,000 | +501.8% | 339,818 | +95.1% | 0.00% | – |
| Q1 2020 | $55,000 | -76.1% | 174,205 | -65.3% | 0.00% | – |
| Q4 2019 | $230,000 | +1177.8% | 502,326 | +4893.3% | 0.00% | – |
| Q3 2019 | $18,000 | -35.7% | 10,060 | 0.0% | 0.00% | – |
| Q2 2019 | $28,000 | -24.3% | 10,060 | 0.0% | 0.00% | – |
| Q1 2019 | $37,000 | – | 10,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 468,620 | $1,336,000 | 1.68% |
| Anson Funds Management LP | 654,762 | $1,866,000 | 0.47% |
| Swift Run Capital | 14,545 | $41,000 | 0.04% |
| Virtu Financial LLC | 11,864 | $34,000 | 0.00% |
| Advisor Group, Inc. | 940 | $3,000 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 667 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 149,875 | $427,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,060 | $28,000 | 0.00% |
| DEUTSCHE BANK AG\ | 200 | $0 | 0.00% |